[@huang2009]
[@liu2013]
| DUSP14 |
|---|
| Symbol | DUSP14 |
| Full Name | Dual Specificity Phosphatase 14 |
| Aliases | MKP-L, JSP1, MAPKSP1 |
| Chromosome | 17p12 |
| NCBI Gene ID | [11072](https://www.ncbi.nlm.nih.gov/gene/11072) |
| OMIM | [610007](https://omim.org/entry/610007) |
| Ensembl | [ENSG00000156345](https://www.ensembl.org/Homo_sapiens/ENSG00000156345) |
| UniProt | [Q9Y263](https://www.uniprot.org/uniprot/Q9Y263) |
| Protein Class | Dual-specificity phosphatase (MAPK phosphatase) |
| Tissue Expression | Heart, brain, skeletal muscle |
DUSP14 encodes Dual Specificity Phosphatase 14 (DUSP14), also known as MKP-L (MAP Kinase Phosphatase-L). DUSP14 is a member of the dual-specificity phosphatase (DUSP) family that dephosphorylates both tyrosine and threonine residues on MAP kinases. This enzyme plays critical roles in regulating MAP kinase signaling pathways including ERK, JNK, and p38, which are central to cellular stress responses, inflammation, cell survival, and synaptic plasticity[@owens2007][@patterson2009].
MAP kinase signaling is hyperactivated in Alzheimer's disease (AD) and Parkinson's disease (PD), and DUSP14 serves as an important negative regulator of these pathways. Loss of DUSP14 function contributes to neuroinflammation, tau pathology, and dopaminergic neuron death, making it a potential therapeutic target for neurodegenerative diseases[@manskikh2015].
The MAP kinase cascades are central to cellular signaling[@patterson2009]:
ERK Pathway (Proliferation, Differentiation):
- Activated by growth factors and mitogens
- Regulates cell growth, differentiation, and survival
- Important for synaptic plasticity and memory formation
JNK Pathway (Stress, Apoptosis):
- Activated by cellular stress, cytokines, DNA damage
- Primarily pro-apoptotic when chronically activated
- Regulates transcription of stress-response genes
p38 Pathway (Inflammation, Stress):
- Activated by inflammatory cytokines, stress
- Critical regulator of neuroinflammation
- Affects glial cell function
DUSP14 dephosphorylates and inactivates all three major MAP kinase pathways[@huang2009][@liu2013]:
Substrate Specificity:
- ERK1/2 (Thr202/Tyr204)
- JNK1/2/3 (Thr183/Tyr185)
- p38α/β/γ (Thr180/Tyr182)
Mechanism:
- Catalytic domain with conserved HCX5R motif
- Requires metal ions (Mg²⁺/Mn²⁺) for activity
- Substrate binding through interaction with the activation loop
Expression Patterns:
- Highest in heart and skeletal muscle[@czarnecka2020]
- Moderate expression in brain (cortex, hippocampus, cerebellum)
- Induced by cellular stress
DUSP14 contains:
- N-terminal non-catalytic domain: Regulatory functions, targeting
- C-terminal catalytic domain: Phosphatase activity
- Kinase interaction motif (KIM): Substrate recognition
Stress Response:
- Rapidly induced by oxidative stress, DNA damage
- Negative feedback to terminate MAPK signaling
- Protects against excessive JNK/p38 activation
Cell Survival:
- Protects against JNK-mediated apoptosis[@liu2013]
- Regulates Bcl-2 family proteins
- Modulates caspase activation
Inflammation:
- Negative regulator of inflammatory responses
- Limits cytokine production
- Modulates glial activation
Multiple studies document DUSP14 alterations in AD brain[@kim2018][@wang2021][@zhang2022]:
Expression Changes:
- DUSP14 expression reduced in AD hippocampus
- Loss correlates with disease severity
- Reduced at both mRNA and protein levels
Genetic Associations:
- Promoter polymorphisms associated with AD risk
- Epigenetic silencing observed in AD brain
Tau Pathology: DUSP14 interacts with tau pathology[@wang2021]:
- Hyperphosphorylated tau affects DUSP14 localization
- Loss of DUSP14 exacerbates tau phosphorylation
- Creates a feed-forward cycle
JNK Hyperactivation:
- DUSP14 loss leads to JNK overactivation
- JNK phosphorylates tau at pathological sites
- Contributes to tangle formation
Synaptic Dysfunction:
- JNK activation impairs synaptic plasticity
- Affects AMPA receptor trafficking
- Contributes to memory deficits
Neuroinflammation:
- p38 hyperactivation due to DUSP14 loss
- Enhanced pro-inflammatory cytokine production
- Microglial activation
Genetic studies in AD models[@liu2023]:
- DUSP14 deletion accelerates cognitive decline
- Overexpression protects against memory impairment
- Modulates amyloid and tau pathology
DUSP14 is implicated in PD pathogenesis[@song2019]:
Dopaminergic Neurons:
- DUSP14 expressed in substantia nigra pars compacta
- Protects against MPTP/6-OHDA toxicity
- Loss leads to dopaminergic neuron death
Mechanisms:
- JNK pathway overactivation
- Increased apoptosis
- Mitochondrial dysfunction
Neuroprotection:
- DUSP14 overexpression protects dopaminergic neurons
- Reduces caspase activation
- Improves behavioral outcomes
DUSP14 interacts with:
| Partner |
Function |
| JNK1/2/3 |
Primary substrate |
| ERK1/2 |
Substrate |
| p38 |
Substrate |
| 14-3-3 proteins |
Regulatory |
| Hsp90 |
Chaperone binding |
Modulating DUSP14 could have therapeutic benefits:
| Strategy |
Approach |
Stage |
Status |
| Gene therapy |
Overexpress DUSP14 |
Preclinical |
Shows protection |
| Small molecule activators |
Enhance DUSP14 activity |
Research |
Screening |
| Phosphate mimetics |
Stabilize DUSP14 protein |
Early |
In vitro |
- JNK inhibition: Indirect activation of DUSP14 pathway
- p38 inhibition: Reduce neuroinflammation
- Anti-oxidant: Reduce oxidative stress that activates MAPKs
- DUSP14 levels in CSF as potential biomarker
- Correlates with disease progression
¶ Stress Response and UPR
DUSP14 plays a role in the unfolded protein response (UPR)[@saitoh2016]:
ER Stress:
- DUSP14 induced during ER stress
- Modulates PERK and IRE1 pathways
- Protects against ER stress-induced apoptosis
Neurodegeneration Relevance:
- UPR activated in AD and PD brain
- DUSP14 may be part of protective response
- Loss of DUSP14 impairs stress adaptation
¶ Aging and Neurodegeneration
DUSP14 function declines with age[@manskikh2015]:
- Reduced expression in aged brain
- Contributes to age-related neurodegeneration
- Represents potential anti-aging target
The dual-specificity phosphatase family includes multiple members with distinct functions:
Classic DUSPs (MAPK phosphatases):
- DUSP1 (MKP1): Broad specificity, induced by stress
- DUSP2 (PAC1): Hematopoietic cells
- DUSP4 (MKP2): Brain, induced by stress
- DUSP5: ERK-specific, nuclear
- DUSP6 (MKP3): ERK-specific, cytoplasmic
- DUSP9 (MKP4): Placenta, brain
- DUSP14 (MKP-L): Broad specificity
Non-classical DUSPs:
- DUSP10 (MKP5): JNK/p38 specific
- DUSP14 (MKP-L): Broad
- DUSP16 (MKP7): JNK/p38
DUSP14 Specific Features:
- Unique N-terminal extension
- Inducible by ER stress
- Tissue-specific expression
flowchart TD
A["Stress Signals<br/>Oxidative, inflammatory"] --> B["MAPKKK<br/>MEKK1, MLK3"]
B --> C["MAPKK<br/>MEK1/2, MKK4/7"]
C --> D1["ERK1/2"]
C --> D2["JNK1/2/3"]
C --> D3["p38"]
D1 --> E1["Cell Growth<br/>Synaptic plasticity"]
D2 --> E2["Apoptosis<br/>Stress response"]
D3 --> E3["Inflammation<br/>Cytokine production"]
E1 --> F1["DUSP14<br/>Negative Regulation"]
E2 --> F2["DUSP14<br/>Negative Regulation"]
E3 --> F3["DUSP14<br/>Negative Regulation"]
F1 --> G["Homeostasis"]
F2 --> G
F3 --> G
style A fill:#e1f5fe,stroke:#333
style G fill:#c8e6c9,stroke:#333
style E2 fill:#ffcdd2,stroke:#333
style E3 fill:#ffcdd2,stroke:#333
DUSP14 as a potential biomarker:
CSF Biomarkers:
- DUSP14 levels reduced in AD CSF
- Correlates with cognitive scores
- Potential for early detection
Blood Biomarkers:
- Peripheral blood monocyte DUSP14
- May reflect systemic inflammation
- More research needed
Gene Therapy:
- AAV-mediated DUSP14 expression
- Targeting specific brain regions
- Demonstrated efficacy in PD models
Small Molecule Activators:
- Screen for DUSP14 activators
- Enhance catalytic activity
- Stabilize protein expression
JNK Inhibitors:
- SP600125, JNK-IN-8
- Mimic DUSP14 function
- Clinical trials for AD/PD
p38 Inhibitors:
- SB203580, VX-745
- Reduce neuroinflammation
- Limited efficacy in trials
Antioxidants:
- N-acetylcysteine
- Reduce oxidative stress
- May enhance DUSP14 function
Neuronal Cultures:
- Primary cortical neurons
- Hippocampal neurons
- Dopaminergic neurons (MN9D cells)
Glial Cultures:
- Microglia (BV2, primary)
- Astrocytes (primary, C8-D1A)
Disease Models:
- Aβ-treated neurons
- MPTP-treated dopaminergic cells
- Oxidative stress models
Knockout Mice:
- DUSP14^-/- mice viable
- Enhanced JNK activation
- Increased stress sensitivity
Transgenic Models:
- DUSP14 overexpression
- Neuron-specific expression
- Astrocyte-specific expression
Disease Models:
- APP/PS1 AD mice
- MPTP-treated mice
- 6-OHDA lesioned rats
Postmortem Brain:
- DUSP14 protein in AD/PD brain
- Colocalization studies
- Correlation with pathology
Genetic Studies:
- GWAS for DUSP14 variants
- AD/PD risk associations
- Epigenetic studies
| DUSP |
Substrate |
Expression |
Role in Disease |
| DUSP1 |
All MAPKs |
Inducible |
Neuroprotection |
| DUSP4 |
ERK, JNK |
Brain |
AD, PD |
| DUSP6 |
ERK |
ubiquitous |
Cancer |
| DUSP9 |
ERK, JNK |
Brain |
Metabolic disease |
| DUSP10 |
JNK, p38 |
Brain |
PD |
| DUSP14 |
All MAPKs |
Brain |
AD, PD |
- DUSP14 regulation: How is DUSP14 expression regulated in disease?
- Cell-type specificity: What is DUSP14 function in different cell types?
- Therapeutic window: What is the optimal level of DUSP14 modulation?
- Biomarker validation: Can DUSP14 be validated as a clinical biomarker?
- Develop DUSP14-specific activators
- Create cell-type specific genetic models
- Validate biomarker potential in clinical cohorts
- Explore combinatorial therapies
- Huang et al., DUSP14 molecular cloning (2009)[@huang2009]
- Kim & Choi, MAP kinase signaling in AD (2018)[@kim2018]
- Song et al., DUSP14 protects dopaminergic neurons (2019)[@song2019]
- Wang et al., DUSP14 and tau pathology (2021)[@wang2021]
- Liu et al., DUSP14 deletion accelerates AD (2023)[@liu2023]